methylbenzethonium chloride and Leishmaniasis, Mucocutaneous

methylbenzethonium chloride has been researched along with Leishmaniasis, Mucocutaneous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J1

Trials

1 trial(s) available for methylbenzethonium chloride and Leishmaniasis, Mucocutaneous

ArticleYear
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin

1995